Precision Medicine News and Research

RSS

AI-based tool revolutionizes prediction of immune response to cancer

In the ongoing fight against cancer, scientists around the globe are exploring innovative approaches to unlock the mysteries of the human immune system -; the complex network of organs, cells and proteins that defends the body against disease.

29 Mar 2024

Research reveals genetic factors in cerebral palsy development

A Canadian-led study has identified genes which may be partially responsible for the development of cerebral palsy.

29 Mar 2024

Using microbiota analysis for health and disease management

The human body harbors approximately 30 trillion microbes, known collectively as the microbiota.

28 Mar 2024

Study explores the role of health care algorithms in racial and ethnic disparities

For years, it was harder for Black patients to secure a coveted spot on the national kidney transplant waitlist because a clinical algorithm was making Black patients appear healthier than they were.

26 Mar 2024

Quibim introduces QP-Liver for enhancing liver disease diagnosis through MRI analysis

Quibim, a global company pioneering imaging biomarkers for precision medicine, is today announcing the launch of a new product, QP-Liver, which improves the diagnosis of diffuse liver diseases through highly accurate quantification of tissue fat and iron from MRI scans. It has been given a CE and UKCA mark for the European Union and United Kingdom respectively, meaning it is cleared to be used in those markets.

24 Mar 2024

Advancing precision personalized medicine for gastric cancer with 3D bioprinting

Gastric cancer ranks among the most widespread diseases in Asian populations, with South Koreans experiencing the third-highest incidence globally in 2020, as reported by the International Agency for Research on Cancer.

21 Mar 2024

Digital twins: Revolutionizing autoimmune disease treatment

Individual patients with autoimmune diseases can receive tailored medication by computationally treating their so-called digital twins with thousands of medications.

20 Mar 2024

Tracking circulating tumor DNA could indicate gastroesophageal cancer treatment response

Monitoring levels of DNA shed by tumors and circulating in the bloodstream could help doctors accurately assess how gastroesophageal cancers are responding to treatment, and potentially predict future prognosis, suggests a new study led by researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.

19 Mar 2024

New insights into upper tract urothelial carcinoma evolution and treatment

Researchers at Weill Cornell Medicine have performed the most comprehensive analysis to date of cancer of the ureters or the urine-collection cavities in the kidney, known as upper tract urothelial carcinoma (UTUC).

18 Mar 2024

MIT researchers develop new method to quickly screen cancer-associated genetic mutations

Tumors can carry mutations in hundreds of different genes, and each of those genes may be mutated in different ways -; some mutations simply replace one DNA nucleotide with another, while others insert or delete larger sections of DNA.

12 Mar 2024

New method developed for triggering and imaging seizures in epilepsy patients

Researchers have developed a new method for triggering and imaging seizures in epilepsy patients, offering physicians the ability to collect real-time data to tailor epilepsy surgery.

11 Mar 2024

Researchers explore the role of vitamin A in pathogenesis of psychiatric disorders

A Newcastle research team has been exploring the role of vitamin A in the pathogenesis of psychiatric disorders.

11 Mar 2024

New PET radiotracer distinguishes diseased tissues based on fructose metabolism

A new PET radiotracer can differentiate diseased tissues from healthy tissues based on fructose metabolism, according to new research published in the March issue of The Journal of Nuclear Medicine.

8 Mar 2024

Transformational $50 million gift from Kenneth C. Griffin to boost Sylvester's research footprint

The University of Miami today announced a transformational $50 million gift from Kenneth C. Griffin, Founder and Chief Executive Officer of Citadel and Founder of Griffin Catalyst, to Sylvester Comprehensive Cancer Center, part of the University of Miami Health System and the Miller School of Medicine.

6 Mar 2024

From China to Uzbekistan - United for Women’s Wellness on IWD

On the occasion of International Women's Day (IWD), BGI Genomics interview Wang Leilei, a trailblazing blind model, and Viktoriya Tsay, an Uzbek advocate of women’s health. Their stories stich a cross-cultural narrative of nurturing the nuance of women’s wellness worldwide.

From BGI Genomics 6 Mar 2024

As a new Core Lab under the Million Microbiomes from Humans Project, MGI empowers INRAE MetaGenoPolis in “Le microbiote français - Le French Gut”project to Propel Metagenomics Research

MGI, a company committed to building core tools and technology to lead life science, announced today a collaboration agreement with MetaGenoPolis, a unit within the renowned National Research Institute for Agriculture, Food and the Environment (INRAE) in France, following MetaGenoPolis' selection as a core lab under the Million Microbiomes from Humans Project (MMHP).

From MGI 6 Mar 2024

MGI Enters Strategic Partnership with Prepaire Labs to Advance Drug Discovery and Precision Medicine

MGI, a company committed to building core tools and technology to lead life science, today announced its collaboration with Prepaire Labs at MEDLAB Middle East 2024 to further empower precision medicine.

From MGI 6 Mar 2024

Harnessing repetitive DNA for early cancer detection

People with cancer have different amounts of a type of repetitive DNA -; called Alu elements -; than people without cancer.

4 Mar 2024

AI and predictive medicine: Recent advances

The potential of deep learning (DL) in enhancing predictive modeling for omics data analysis.

4 Mar 2024

AI-based technology unlocks secrets of myasthenic-congenital syndromes

An international team of scientists led by ICREA researcher and Director of the Life Sciences Department at the Barcelona Supercomputing Centre - Centro Nacional de Supercomputación (BSC-CNS), Alfonso Valencia, has developed a technology based on artificial intelligence (AI) for the study of minority diseases and has successfully applied it to identify the possible causes of the appearance of what are known as myasthenic-congenital syndromes, a group of rare inherited disorders that limit the ability to move and cause varying degrees of muscle weakness in patients.

28 Feb 2024

Precision Medicine News and Research

AI-based tool revolutionizes prediction of immune response to cancer

Research reveals genetic factors in cerebral palsy development

Using microbiota analysis for health and disease management

Study explores the role of health care algorithms in racial and ethnic disparities

Quibim introduces QP-Liver for enhancing liver disease diagnosis through MRI analysis

Advancing precision personalized medicine for gastric cancer with 3D bioprinting

Digital twins: Revolutionizing autoimmune disease treatment

Tracking circulating tumor DNA could indicate gastroesophageal cancer treatment response

New insights into upper tract urothelial carcinoma evolution and treatment

MIT researchers develop new method to quickly screen cancer-associated genetic mutations

New method developed for triggering and imaging seizures in epilepsy patients

Researchers explore the role of vitamin A in pathogenesis of psychiatric disorders

New PET radiotracer distinguishes diseased tissues based on fructose metabolism

Transformational $50 million gift from Kenneth C. Griffin to boost Sylvester's research footprint

From China to Uzbekistan - United for Women’s Wellness on IWD

As a new Core Lab under the Million Microbiomes from Humans Project, MGI empowers INRAE MetaGenoPolis in “Le microbiote français - Le French Gut”project to Propel Metagenomics Research

MGI Enters Strategic Partnership with Prepaire Labs to Advance Drug Discovery and Precision Medicine

Harnessing repetitive DNA for early cancer detection

AI and predictive medicine: Recent advances

AI-based technology unlocks secrets of myasthenic-congenital syndromes

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News